Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Novak

Showing results (251-260 of 331) with videos related to

Pageof 34
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 29, 2014
Interatrial pressure gradients during simulated obstructive sleep apnea: a catheter-based studyTomas Konecny, Amber D Khanna, Jan Novak, et al.
Journal of Molecular Biology|April 10, 2007
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cellsMilan Raska, Zina Moldoveanu, Hitoshi Suzuki, et al.
Neuroimage. Clinical|February 8, 2020
Distinguishing between paediatric brain tumour types using multi-parametric magnetic resonance imaging and machine learning: A multi-site studyJames T Grist, Stephanie Withey, Lesley MacPherson, et al.
Kidney Diseases (Basel, Switzerland)|November 17, 2015
New Insights into the Pathogenesis of IgA NephropathyJan Novak, Dana Rizk, Kazuo Takahashi, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2014
Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA NephropathyLi Zhu, Ya-Ling Zhai, Feng-Mei Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathyRoberta Camilla, Hitoshi Suzuki, Valentina Daprà, et al.
Pediatric Radiology|March 15, 2022
Dynamic susceptibility-contrast magnetic resonance imaging with contrast agent leakage correction aids in predicting grade in pediatric brain tumours: a multicenter studyStephanie B Withey, Lesley MacPherson, Adam Oates, et al.
Haematologica|January 13, 2022
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trialCarol Moreno, Richard Greil, Fatih Demirkan, et al.
Contributions to Nephrology|May 15, 2007
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cellsJan Novak, Zina Moldoveanu, Matthew B Renfrow, et al.
The Journal of Clinical Investigation|May 30, 2009
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityHitoshi Suzuki, Run Fan, Zhixin Zhang, et al.
Pageof 34

Showing results (251-260 of 331) with videos related to

Sort By:
Pageof 34
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 29, 2014
Interatrial pressure gradients during simulated obstructive sleep apnea: a catheter-based studyTomas Konecny, Amber D Khanna, Jan Novak, et al.
Journal of Molecular Biology|April 10, 2007
Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cellsMilan Raska, Zina Moldoveanu, Hitoshi Suzuki, et al.
Neuroimage. Clinical|February 8, 2020
Distinguishing between paediatric brain tumour types using multi-parametric magnetic resonance imaging and machine learning: A multi-site studyJames T Grist, Stephanie Withey, Lesley MacPherson, et al.
Kidney Diseases (Basel, Switzerland)|November 17, 2015
New Insights into the Pathogenesis of IgA NephropathyJan Novak, Dana Rizk, Kazuo Takahashi, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2014
Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA NephropathyLi Zhu, Ya-Ling Zhai, Feng-Mei Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathyRoberta Camilla, Hitoshi Suzuki, Valentina Daprà, et al.
Pediatric Radiology|March 15, 2022
Dynamic susceptibility-contrast magnetic resonance imaging with contrast agent leakage correction aids in predicting grade in pediatric brain tumours: a multicenter studyStephanie B Withey, Lesley MacPherson, Adam Oates, et al.
Haematologica|January 13, 2022
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab <i>versus</i> chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trialCarol Moreno, Richard Greil, Fatih Demirkan, et al.
Contributions to Nephrology|May 15, 2007
IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cellsJan Novak, Zina Moldoveanu, Matthew B Renfrow, et al.
The Journal of Clinical Investigation|May 30, 2009
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityHitoshi Suzuki, Run Fan, Zhixin Zhang, et al.
Pageof 34